JAZZ PHARMACEUTICALS PARTNERS WITH WESTWOOD & WILSHIRE TO FILL MEDICAL DIRECTOR, HEMATOLOGY ONCOLOGY

Dr. Shirali Agarwal has joined Jazz Pharmaceuticals as their new Medical Director, Hematology Oncology. Dr. Agarwal joins Jazz from Seattle Children’s Hospital and Fred Hutchinson Cancer Research Center, where he served as a physician and Clinical Research Investigator. In addition to a Fellowship of Indian Academy of Pediatrics in Pediatric hematology Oncology and Bone Marrow Transplantation, Dr. Agarwal has held positions of increasing related responsibility at BLK Super Specialty Hospital, Rainbow Children’s Hospital, a WHO Collaborating Centre for Research throughout his career.

The search was successfully led by Chris Tillman at Westwood & Wilshire.

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California with additional offices in Silicon Valley, we serve our clients on a local, national and global basis.

Previous
Previous

RIBOMETRIX PARTNERS WITH WESTWOOD & WILSHIRE TO FILL VICE PRESIDENT - LEAD DISCOVERY AND RESEARCH OPERATIONS

Next
Next

AGIOS PHARMACEUTICALS, INC. PARTNERS WITH WESTWOOD & WILSHIRE TO FILL DIRECTOR, CLINICAL SCIENCE ROLE